kabutan

Perseus Proteomics, The Current Fiscal Year's Undisclosed Net Income to Narrow

Mon Mar 31, 2025 3:30 pm JST Revision

4882 Perseus Proteomics Inc. 【J-GAAP】

Guidance Update Report

Perseus Proteomics Inc. <4882> [TSE Growth] announced a previously undisclosed earnings forecast after the market closed on March 31st (15:30). The net loss (non-consolidated) for the fiscal year ending March 2025 is expected to further decrease to loss of 0.92 billion yen (compared to a loss of 1.1 billion yen in the previous period).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev ー ー ー ー － 0 May 15, 2024 J-GAAP
Oct - Mar, 2024 New 61 -429 -419 -425 -29.8 0 Mar 31, 2025 J-GAAP
Revision Rate － － － － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev ー ー ー ー － 0 May 15, 2024 J-GAAP
Mar, 2025 New 120 -843 -846 -920 -64.5 0 Mar 31, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 50 -450 -450 -471 -40.0 0 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 61 -429 -419 -425 -29.8 0 Mar 31, 2025 J-GAAP
YoY +22.0% +4.7% +6.9% +9.8% +25.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 94 -697 -689 -786 -66.9 0 May 12, 2023 J-GAAP
Mar, 2024 100 -894 -879 -1,104 -93.7 0 May 15, 2024 J-GAAP
Mar, 2025 Guidance 120 -843 -846 -920 -64.5 0 Mar 31, 2025 J-GAAP
YoY +20.0% +5.7% +3.8% +16.7% +31.2%

Related Articles